In that study, the meal replacement group had a pronounced reduction in adipokines fetuin A and resistin compared to the lifestyle group, reinforcing the potential anti-obesity effect of soy in humans. The gene discussed is RETN; the disease is obesity due to melanocortin 4 receptor deficiency.